BioAge Labs, Inc (BIOA) insider trading
Every open-market stock purchase and sale by BioAge Labs, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $7.8M over the last 12 months (9 sales). No open-market buys.
- Last insider buy: Vijay Satyanand Pande (Insider), $504K, 1 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $7.8M (9 sales). Last close $25.10 on Jul 2, 2026.
Recent BIOA insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 30, 2026 | Shane Barton (Insider) | Sold | $509K |
| Jun 30, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 30, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 30, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 30, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Shane Barton (Insider) | Sold | $1.1M |
| Jun 29, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 29, 2026 | Shane Barton (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Michael H. Davidson (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Rekha Hemrajani (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Vijay Satyanand Pande (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Jean Pierre Garnier (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | James Healy (Insider) | Bought (not open market) | — |
| Jun 10, 2026 | Patrick G Enright (Insider) | Bought (not open market) | — |
| Apr 23, 2026 | Dov A Goldstein Md (CFO) | Bought (not open market) | — |
| Apr 1, 2026 | Paul D Rubin (C-suite exec) | Sold | $157K |
| Apr 1, 2026 | Paul D Rubin (C-suite exec) | Bought (not open market) | — |
| Apr 1, 2026 | Paul D Rubin (C-suite exec) | Bought (not open market) | — |
| Mar 2, 2026 | Paul D Rubin (C-suite exec) | Sold | $151K |
| Mar 2, 2026 | Paul D Rubin (C-suite exec) | Bought (not open market) | — |
| Mar 2, 2026 | Paul D Rubin (C-suite exec) | Bought (not open market) | — |
| Mar 1, 2026 | Dov A Goldstein Md (CFO) | Bought (not open market) | — |
| Feb 17, 2026 | Kristen Fortney (CEO) | Bought (not open market) | — |
Who's trading BIOA
- Shane Barton, Insider: sold $1.6M (2 sales), last Jun 30, 2026
- Vijay Satyanand Pande, Insider: other filings, last Jun 10, 2026
- Michael H. Davidson, Insider: other filings, last Jun 10, 2026
- James Healy, Insider: other filings, last Jun 10, 2026
- Rekha Hemrajani, Insider: other filings, last Jun 10, 2026
- Jean Pierre Garnier, Insider: other filings, last Jun 10, 2026
- Patrick G Enright, Insider: other filings, last Jun 10, 2026
- Dov A Goldstein Md, CFO: sold $532K (4 sales), last Apr 23, 2026
- Paul D Rubin, C-suite exec: sold $1.5M (6 sales), last Apr 1, 2026
- Kristen Fortney, CEO: sold $4.2M (1 sale), last Feb 17, 2026
- Eric Morgen, COO: other filings, last Feb 17, 2026
Get free alerts when an insider at BioAge Labs, Inc files a new trade →